Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Miyakoshi J et al. | 2000 | intact cell/cell culture, MO54 cells (derived from a human malignant glioma) | magnetic field, 50/60 Hz, co-exposure | 5–400 mT |
| Morabito C et al. | 2017 | - | magnetic field, 50/60 Hz | - |
| Mousavi Maleki NS et al. | 2022 | intact cell/cell culture, human adenocarcinoma gastric cancer cell line (AGS) | magnetic field, 50/60 Hz | - |
| Moya-Gómez A et al. | 2023 | intact cell/cell culture, BV2 cells (immortalized murine microglial cell line), SHSY5Y cells, (immortalized human neuroblastoma cell line), primary mouse microglia and neurons, animal, mongolian gerbils <i>(Meriones unguiculatus)</i> (stroke model) | 50/60 Hz, magnetic field | - |
| Nakayama M et al. | 2016 | intact cell/cell culture, macrophages (RAW 246) | magnetic field, 50/60 Hz, co-exposure | 500 µT |
| Nawrotek P et al. | 2014 | bacterium, <i>Escherichia coli</i>/O157:H7 and E68II/0141 and <i>Staphylococcus aureus</i>/FRI 913, ATCC 25923 and ATCC 43300 | magnetic field, 50/60 Hz | 30 mT |
| Nguyen H et al. | 2023 | intact cell/cell culture, TK6 cells (lymphoblastoma cells) | magnetic field, 50/60 Hz | - |
| Nieminen V et al. | 2022 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | static magnetic field, magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | - |
| Novak J et al. | 2007 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>) | magnetic field, 50/60 Hz | 5.2–10 mT |
| Nurković J et al. | 2017 | - | magnetic field, 50/60 Hz, low frequency, also other exposures without EMF, co-exposure | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
